Company Intelligence

NeuroX1

NeuroX1 provides enterprise-grade artificial intelligence solutions, delivering specialized NeuroX1 Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Headquarters
Austin, Americas
Founded
2024
Stage
Techstars Industries of the Future Accelerator
Status
Active
Products
1
Reports
4
Last reviewed
Aug 2026
AI in Enterprise Software Techstars Industries of the Future Accelerator Active

Overview

What this company is, what it builds, and who it serves.

NeuroX1 is an Enterprise Software AI company based in Austin, Americas, founded in 2024.

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

What it builds

NeuroX1 Platform

Why It Matters

NeuroX1 provides enterprise-grade artificial intelligence solutions, delivering specialized NeuroX1 Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Products

Products and platforms connected to this company.

  • NeuroX1 Enterprise Software

    Explore NeuroX1 by NeuroX1. Verified AI product intelligence covering core capabilities, Enterprise Software use cases, technical architecture, and…

    View product intelligence

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

NeuroX1

Products

Capabilities

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

Features

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

Country

Americas

Official Resources

Official and developer links on file for this company.

Frequently Asked Questions

What does NeuroX1 do?

NeuroX1 specializes in artificial intelligence, developing NeuroX1 Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.

Where is NeuroX1 based and when was it founded?

NeuroX1 is based in Americas and was founded in 2024.

What are the main products offered by NeuroX1?

The flagship platform from NeuroX1 is NeuroX1 Platform, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of NeuroX1?

NeuroX1 primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Primary sources

Request a correction if you represent this company or believe information is inaccurate.